ID

16383

Description

Randomized Trial With Trastuzumab Versus Observation in Breast Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00429247

Link

https://clinicaltrials.gov/show/NCT00429247

Keywords

  1. 7/14/16 7/14/16 -
Uploaded on

July 14, 2016

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Cancer NCT00429247

Eligibility Breast Cancer NCT00429247

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age >= 18 years.
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
performance status (world health organization [who]) < 3
Description

WHO performance status scale

Data type

boolean

Alias
UMLS CUI [1]
C1298650
adequate bone marrow function (absolute neutrophil count > 1000/mm^3, platelet count > 100000/mm^3, hemoglobin > 9 gr/mm^3)
Description

Bone Marrow function | Absolute neutrophil count | Platelet Count measurement | Hemoglobin

Data type

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0948762
UMLS CUI [3]
C0032181
UMLS CUI [4]
C0019046
adequate liver (bilirubin < 1.5 times upper limit of normal and sgot/sgpt < 2 times upper limit of normal) and renal function ( creatinine < 2 mg/dl)
Description

Liver function | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Renal function | Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0201899
UMLS CUI [4]
C0201836
UMLS CUI [5]
C0232804
UMLS CUI [6]
C0201976
adequate cardiac function (left ventricular ejection fraction [lvef] > 50%).
Description

Cardiac function | Left ventricular ejection fraction

Data type

boolean

Alias
UMLS CUI [1]
C0232164
UMLS CUI [2]
C0428772
informed consent
Description

Informed consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
histologically or cytologically confirmed breast adenocarcinoma
Description

Breast adenocarcinoma

Data type

boolean

Alias
UMLS CUI [1]
C0858252
prior surgical excision of the primary breast tumor
Description

Excision Primary malignant neoplasm of breast

Data type

boolean

Alias
UMLS CUI [1,1]
C0728940
UMLS CUI [1,2]
C1299258
prior completion of standard adjuvant chemotherapy and/or radiotherapy
Description

Adjuvant Chemotherapy Complete | Adjuvant Radiotherapy Complete

Data type

boolean

Alias
UMLS CUI [1,1]
C0085533
UMLS CUI [1,2]
C0205197
UMLS CUI [2,1]
C0242939
UMLS CUI [2,2]
C0205197
locally advanced disease after the completion of neo-adjuvant chemotherapy, surgical excision and radiotherapy provided that there was no evidence of local or metastatic disease
Description

Locally Advanced Malignant Neoplasm | Neoadjuvant Chemotherapy Complete | Excision | Therapeutic radiology procedure | Localized Malignant Neoplasm Evidence of | Metastatic Neoplasm Evidence of

Data type

boolean

Alias
UMLS CUI [1]
C0677984
UMLS CUI [2,1]
C0600558
UMLS CUI [2,2]
C0392920
UMLS CUI [2,3]
C0205197
UMLS CUI [3]
C0728940
UMLS CUI [4]
C1522449
UMLS CUI [5,1]
C0796563
UMLS CUI [5,2]
C0332120
UMLS CUI [6,1]
C2939420
UMLS CUI [6,2]
C0332120
absence of any clinical or laboratory evidence of metastatic disease
Description

Metastatic Neoplasm Evidence Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C2939420
UMLS CUI [1,2]
C0332120
UMLS CUI [1,3]
C0332197
detection of ctcs and/or dtcs (when it could be feasible) before the initiation and/or after the completion of adjuvant chemotherapy and/or radiotherapy
Description

Circulating Tumor Cells Detection | Disseminated Tumor Cells Detection | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant

Data type

boolean

Alias
UMLS CUI [1,1]
C0027625
UMLS CUI [1,2]
C1511790
UMLS CUI [2,1]
C3273605
UMLS CUI [2,2]
C1511790
UMLS CUI [3]
C0085533
UMLS CUI [4]
C0242939
expression of her2/c-neu on the primary tumor is not mandatory
Description

HER-2 neu Expression primary tumor

Data type

boolean

Alias
UMLS CUI [1,1]
C0242957
UMLS CUI [1,2]
C0017262
UMLS CUI [1,3]
C0677930
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
other invasive malignancy within the past 5 years except nonmelanoma skin cancer
Description

Malignant Neoplasm Invasive | Skin carcinoma

Data type

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0205281
UMLS CUI [2]
C0699893
other concurrent uncontrolled illness
Description

Illness Uncontrolled

Data type

boolean

Alias
UMLS CUI [1,1]
C0221423
UMLS CUI [1,2]
C0205318
psychiatric illness or social situation that would preclude study compliance
Description

Mental disorders Compliance behavior Limited | social situation Compliance behavior Limited

Data type

boolean

Alias
UMLS CUI [1,1]
C0004936
UMLS CUI [1,2]
C1321605
UMLS CUI [1,3]
C0439801
UMLS CUI [2,1]
C0748872
UMLS CUI [2,2]
C1321605
UMLS CUI [2,3]
C0439801
pregnant or nursing
Description

Pregnancy | Breast Feeding

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
positive pregnancy test
Description

Pregnancy test positive

Data type

boolean

Alias
UMLS CUI [1]
C0240802
history of allergic reaction attributed to trastuzumab (herceptin)
Description

Allergic Reaction trastuzumab | Allergic Reaction Herceptin

Data type

boolean

Alias
UMLS CUI [1,1]
C1527304
UMLS CUI [1,2]
C0728747
UMLS CUI [2,1]
C1527304
UMLS CUI [2,2]
C0338204

Similar models

Eligibility Breast Cancer NCT00429247

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age >= 18 years.
boolean
C0001779 (UMLS CUI [1])
WHO performance status scale
Item
performance status (world health organization [who]) < 3
boolean
C1298650 (UMLS CUI [1])
Bone Marrow function | Absolute neutrophil count | Platelet Count measurement | Hemoglobin
Item
adequate bone marrow function (absolute neutrophil count > 1000/mm^3, platelet count > 100000/mm^3, hemoglobin > 9 gr/mm^3)
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0948762 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0019046 (UMLS CUI [4])
Liver function | Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Renal function | Creatinine measurement, serum
Item
adequate liver (bilirubin < 1.5 times upper limit of normal and sgot/sgpt < 2 times upper limit of normal) and renal function ( creatinine < 2 mg/dl)
boolean
C0232741 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0201899 (UMLS CUI [3])
C0201836 (UMLS CUI [4])
C0232804 (UMLS CUI [5])
C0201976 (UMLS CUI [6])
Cardiac function | Left ventricular ejection fraction
Item
adequate cardiac function (left ventricular ejection fraction [lvef] > 50%).
boolean
C0232164 (UMLS CUI [1])
C0428772 (UMLS CUI [2])
Informed consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Breast adenocarcinoma
Item
histologically or cytologically confirmed breast adenocarcinoma
boolean
C0858252 (UMLS CUI [1])
Excision Primary malignant neoplasm of breast
Item
prior surgical excision of the primary breast tumor
boolean
C0728940 (UMLS CUI [1,1])
C1299258 (UMLS CUI [1,2])
Adjuvant Chemotherapy Complete | Adjuvant Radiotherapy Complete
Item
prior completion of standard adjuvant chemotherapy and/or radiotherapy
boolean
C0085533 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0242939 (UMLS CUI [2,1])
C0205197 (UMLS CUI [2,2])
Locally Advanced Malignant Neoplasm | Neoadjuvant Chemotherapy Complete | Excision | Therapeutic radiology procedure | Localized Malignant Neoplasm Evidence of | Metastatic Neoplasm Evidence of
Item
locally advanced disease after the completion of neo-adjuvant chemotherapy, surgical excision and radiotherapy provided that there was no evidence of local or metastatic disease
boolean
C0677984 (UMLS CUI [1])
C0600558 (UMLS CUI [2,1])
C0392920 (UMLS CUI [2,2])
C0205197 (UMLS CUI [2,3])
C0728940 (UMLS CUI [3])
C1522449 (UMLS CUI [4])
C0796563 (UMLS CUI [5,1])
C0332120 (UMLS CUI [5,2])
C2939420 (UMLS CUI [6,1])
C0332120 (UMLS CUI [6,2])
Metastatic Neoplasm Evidence Absent
Item
absence of any clinical or laboratory evidence of metastatic disease
boolean
C2939420 (UMLS CUI [1,1])
C0332120 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Circulating Tumor Cells Detection | Disseminated Tumor Cells Detection | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant
Item
detection of ctcs and/or dtcs (when it could be feasible) before the initiation and/or after the completion of adjuvant chemotherapy and/or radiotherapy
boolean
C0027625 (UMLS CUI [1,1])
C1511790 (UMLS CUI [1,2])
C3273605 (UMLS CUI [2,1])
C1511790 (UMLS CUI [2,2])
C0085533 (UMLS CUI [3])
C0242939 (UMLS CUI [4])
HER-2 neu Expression primary tumor
Item
expression of her2/c-neu on the primary tumor is not mandatory
boolean
C0242957 (UMLS CUI [1,1])
C0017262 (UMLS CUI [1,2])
C0677930 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Malignant Neoplasm Invasive | Skin carcinoma
Item
other invasive malignancy within the past 5 years except nonmelanoma skin cancer
boolean
C0006826 (UMLS CUI [1,1])
C0205281 (UMLS CUI [1,2])
C0699893 (UMLS CUI [2])
Illness Uncontrolled
Item
other concurrent uncontrolled illness
boolean
C0221423 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Mental disorders Compliance behavior Limited | social situation Compliance behavior Limited
Item
psychiatric illness or social situation that would preclude study compliance
boolean
C0004936 (UMLS CUI [1,1])
C1321605 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])
C0748872 (UMLS CUI [2,1])
C1321605 (UMLS CUI [2,2])
C0439801 (UMLS CUI [2,3])
Pregnancy | Breast Feeding
Item
pregnant or nursing
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Pregnancy test positive
Item
positive pregnancy test
boolean
C0240802 (UMLS CUI [1])
Allergic Reaction trastuzumab | Allergic Reaction Herceptin
Item
history of allergic reaction attributed to trastuzumab (herceptin)
boolean
C1527304 (UMLS CUI [1,1])
C0728747 (UMLS CUI [1,2])
C1527304 (UMLS CUI [2,1])
C0338204 (UMLS CUI [2,2])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial